Study cohort characteristics (Swedish Watchful Waiting Cohort II: stained for α-catenin)
| No of patients | 411 |
| Mean age, years | |
| Age at diagnosis | 73.93 (51–91) |
| Gleason score | n (%) |
| 4 | 5 (1.6) |
| 5 | 14 (2.5) |
| 6 | 104 (39.2) |
| 7 | 185 (35.6) |
| 8 | 47 (9.3) |
| 9 | 53 (10.3) |
| 10 | 3 (1.6) |
| % Chips with cancer | |
| <5 | 74 (18.0) |
| 5–25 | 197 (47.9) |
| 26–50 | 63 (15.3) |
| >50 | 77 (18.7) |
| t-Stage | |
| T1a | 74 (18.0) |
| T1b | 337 (82.0) |
| Cause of death | |
| PC death | 72 (17.5) |
| Non-PC death | 272 (66.2) |
| Still alive | 67 (16.3) |
PC, prostate cancer.